Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Bullboard Posts
Comment by MoneyManager313on Jun 20, 2018 6:58pm
207 Views
Post# 28202378

RE:Fully Diluted Share Count

RE:Fully Diluted Share CountCurrent profit margins are 30% for Aphria. In 2019, Aphria expects profit margins to increase with streamline operations to 42% profit margin. Simply put,  every gram Aphria sells they make a profit of 2.86$ per gram in pocket. This is assuming average sale price of 6.82 per gram in store. I Know i low balled the price per gram, but im basing it on Oregons supplu and demand projections. Simply put,  2.86$ x .70 % (projected sale of product @ 70% production) x 175 million grams produced = 351 million in pocket (pure profit baby!) divided by shares (225 million with dilution) = eps 1.56 per share x 48 X projected multiple = 74.88 per share.

2019 you will likely see 74.88 $ per share. 

You're gonna see analysts start increasing price projections on Aphria.  Which is already at 20 low 25 med and $27 per share high.  

Bullboard Posts